Lipocine, Inc. (LPCN) Issued Patent Related to Compositions Having Testosterone Undecanoate
Tweet Send to a Friend
Lipocine Inc. (Nasdaq: LPCN), a specialty pharmaceutical company, today announced that the United States Patent and Trademark Office (USPTO) has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
